| Component: (Network and Table) | |
|---|---|
| Network | 00100 - Statement - Consolidated Balance Sheets (http://www.acadia-pharm.com/role/StatementConsolidatedBalanceSheets) |
| Table | (Implied) |
| Reporting Entity [Axis] | 0001070494 (http://www.sec.gov/CIK) |
| Consolidated Balance Sheets [Abstract] | Period [Axis] | |||
|---|---|---|---|---|
2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | |
Consolidated Balance Sheets [Abstract] | ||||
Assets | ||||
Cash and cash equivalents | 6,889,000 | 6,849,000 | 18,122,000 | 21,171,000 |
Investment securities, available-for-sale | 24,159,000 | 30,238,000 | ||
Prepaid expenses, receivables and other current assets | 901,000 | 762,000 | ||
Total current assets | 31,949,000 | 37,849,000 | ||
Property and equipment, net | 151,000 | 426,000 | ||
Other assets | 14,000 | 119,000 | ||
Total assets | 32,114,000 | 38,394,000 | ||
Liabilities and stockholders' equity | ||||
Accounts payable | 1,960,000 | 1,972,000 | ||
Accrued expenses | 3,504,000 | 3,219,000 | ||
Current portion of deferred revenue | 669,000 | 690,000 | ||
Current portion of long-term debt | 32,000 | 78,000 | ||
Total current liabilities | 6,165,000 | 5,959,000 | ||
Long-term portion of deferred revenue | 2,587,000 | 2,623,000 | ||
Other long-term liabilities | 124,000 | |||
Total liabilities | 8,752,000 | 8,706,000 | ||
Commitments and contingencies (Note 10) | xsi:nil | xsi:nil | ||
Stockholders' equity | ||||
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2011 and 2010; no shares issued and outstanding at December 31, 2011 and 2010 | xsi:nil | xsi:nil | ||
Common stock, $0.0001 par value; 150,000,000 and 75,000,000 shares authorized at December 31, 2011 and December 31, 2010, respectively; 52,898,659 shares and 39,350,561 shares issued and outstanding at December 31, 2011 and December 31, 2010, respectively | 5,000 | 4,000 | ||
Additional paid-in capital | 370,219,000 | 353,278,000 | ||
Accumulated deficit | (346,871,000) | (324,106,000) | ||
Accumulated other comprehensive income | 9,000 | 512,000 | ||
Total stockholders' equity | 23,362,000 | 29,688,000 | 12,114,000 | 52,992,000 |
Total liabilities and stockholders' equity | 32,114,000 | 38,394,000 | ||